Provision Supported by Sen. Shaheen, Collins to Help Reduce Insulin Costs for Diabetes Patients Signed Into Law
January 03, 2020
January 03, 2020
WASHINGTON, Jan. 3 -- Sen. Jeanne Shaheen, D-New Hampshire, issued the following news release:
U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME, the co-chairs of the Senate Diabetes Caucus, announced that a provision they advocated for to help increase competition in the insulin market and reduce costs for diabetes patients has been signed into law as part of the appropriations package.
The new law incorporates a component of the Lower Health Care Costs Act t . . .
U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME, the co-chairs of the Senate Diabetes Caucus, announced that a provision they advocated for to help increase competition in the insulin market and reduce costs for diabetes patients has been signed into law as part of the appropriations package.
The new law incorporates a component of the Lower Health Care Costs Act t . . .